Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Journavx pharmaceutical company?

See the DrugPatentWatch profile for Journavx

Journavx is the brand name for eluxadoline, a drug used for irritable bowel syndrome with diarrhea (IBS-D). The pharmaceutical company behind Journavx is Phathom Pharmaceuticals.

Who makes Journavx?

Phathom Pharmaceuticals is the company that markets Journavx (eluxadoline).[1]

What is Journavx used for?

Journavx (eluxadoline) is prescribed for IBS-D (irritable bowel syndrome with diarrhea).[1]

Is there information on patents or exclusivity for Journavx?

DrugPatentWatch.com tracks patent and exclusivity activity for branded drugs like Journavx and can be used to look up relevant filings and timelines.[2]

Sources

[1] https://www.drugs.com/mtm/journavx.html
[2] https://www.drugpatentwatch.com/



Other Questions About Journavx :

Journavx tolerability clinical trials rating? How does the FDA-approved Journavx treat moderate pain? Journavx for chronic pain?